Allied Market Research published a report, titled, 'Respiratory Inhaler Devices Market by Product (Metered Dose Inhalers, Dry ...
Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
The use of inhaled corticosteroids during pregnancy may protect against reduced lung function in infants born to mothers with ...
Maryland lawmakers introduce the Affordable Inhalers and Nebulizers Act to reduce the cost of inhalers and expand Medicare ...
Festive triggers like trees, certain food and drinks and even gifts could land you in hospital this Christmas, warns Asthma + Lung UK ...
MedPage Today on MSN
First Twice-Yearly Biologic Approved for Severe Eosinophilic Asthma
The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for ...
Pittsburgh Steelers defensive tackle Cameron Heyward was diagnosed with asthma as a child and has had to manage it throughout his Ohio State and NFL football career.
Cipla has launched Afrezza, an inhaled insulin powder, offering a needle-free alternative to traditional injectable insulin therapy for diabetes patients.
Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...
DK Metcalf’s rare blend of size and speed makes headlines, but his asthma journey reveals an even deeper mental edge.
If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist (LAMA) or a Leukotriene Receptor Antagonist (LTRA) on top of a moderate-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results